Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron-Reference-Cited by-同舟云学术

Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron

Published:2002-10 Issue:4 Volume:123 Page:969-977
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Berman Steven M.,Chang Lin,Suyenobu Brandall,Derbyshire Stuart W.,Stains Jean,FitzGerald Leah,Mandelkern Mark,Hamm Lynn,Vogt Brent,Naliboff Bruce D.,Mayer Emeran A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference43 articles.

1. Emerging disease model for functional gastrointestinal disorders;Mayer;Am J Med,1999

2. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised placebo-controlled trial;Camilleri;Lancet,2000

3. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome;Lembo;Am J Gastroenterol,2001

4. Cilansetron shows efficacy in non-constipated irritable bowel syndrome patients independent of the definition of the patient population by ROME I or ROME II;Caras;Gastroenterology,2001

5. Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin-induced nausea and vomiting;Cubeddu;N Engl J Med,1990

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. General and anxiety-linked influences of acute serotonin reuptake inhibition on neural responses associated with attended visceral sensation;Translational Psychiatry;2024-06-06

2. General and Anxiety-Linked Influence of Acute Serotonin Reuptake Inhibition on Neural Responses Associated with Attended Visceral Sensation;2024-01-23

3. The neurobiology of irritable bowel syndrome;Molecular Psychiatry;2023-02-02

4. Synthesis and Development of Indole Based 5-HT3 Receptor Antagonists as Anti-Emetic Drugs in Oncology: An Update;Current Medicinal Chemistry;2021-12

5. Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial;Scientific Reports;2021-07-06